Autonomix medical, inc. (nasdaq: amix) participates in virtual investor “what this means” segment

Dr. robert schwartz, chief medical officer of autonomix, discusses the company's recently announced results from the post hoc analysis of its proof-of-concept human clinical trial (“poc 1”)
AMIX Ratings Summary
AMIX Quant Ranking